- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
13
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
13 companies
Axsome Therapeutics
Market Cap: US$12.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$217.99
7D
-9.5%
1Y
111.6%
Madrigal Pharmaceuticals
Market Cap: US$11.4b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$467.32
7D
-14.2%
1Y
54.7%
PTC Therapeutics
Market Cap: US$6.3b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$68.02
7D
-11.5%
1Y
30.5%
Veracyte
Market Cap: US$4.8b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$46.19
7D
-18.4%
1Y
95.4%
Vera Therapeutics
Market Cap: US$2.4b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
VERA
US$32.10
7D
-9.4%
1Y
53.2%
Iovance Biotherapeutics
Market Cap: US$2.1b
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
IOVA
US$4.07
7D
-18.4%
1Y
51.9%
Syndax Pharmaceuticals
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$19.05
7D
-8.5%
1Y
90.9%
Equillium
Market Cap: US$146.7m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States.
EQ
US$2.20
7D
-11.6%
1Y
209.9%
PepGen
Market Cap: US$123.1m
A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.
PEPG
US$1.76
7D
-8.8%
1Y
33.3%
Polyrizon
Market Cap: US$21.8m
A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
PLRZ
US$11.25
7D
-23.4%
1Y
72.0%
Galera Therapeutics
Market Cap: US$16.2m
A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.
GRTX.D
US$15.62
7D
-10.7%
1Y
239.6%
Numinus Wellness
Market Cap: US$10.3m
Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.
NUMI.F
US$0.031
7D
-23.0%
1Y
35.1%
International Stem Cell
Market Cap: US$2.1m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.27
7D
-15.3%
1Y
65.2%